Biopreservation Market Report
RA00369
Biopreservation Market, by Type [Media, Equipment (Alarms, Freezers, Thawing Equipment), and LIMS), Biospecimen (Stem Cells, Human Tissue, and Organs), Application (Therapeutic, Research, and Clinical Trials), End User (Hospitals and Biobank), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2020–2027
Biopreservation Market Analysis:
Biopreservation is the process or technique which helps in preserving biospecimens such as cells, DNA, saliva, and plasma. Biopreservation keeps the biospecimens intact and protects them from getting damaged outside their natural environment for a longer time. long-term storage capabilities increase the efficiency of the preservation process. Biopreservation is utilized in multiple healthcare institutes and setups for retaining the functionality and integrity of various clinical trial materials, eggs, sperm, embryos, and others. The biopreservation process ensures the purity and stability of biospecimens and increases shelf life as well. Medical researches related to personalized medicine and genomics research is widely using biobanking, a type of biopreservation. Growing applications and demand owing to various benefits have facilitated the market growth.
Rising prevalence of chronic diseases, development of regenerative medicine, and growing biospecimen testing are the major factors driving the market growth
One of the major factors driving the market growth is the rising prevalence of chronic diseases and obesity across the globe. Growing patients of chronic diseases like diabetes, cardiac, degenerative conditions affecting the joints, nerves, bones, and others are increasing demand for biopreservation. As per an updated report from the World Health Organization (WHO) from September 2019, more than 17 million people die annually due to cardiovascular diseases, making it the number one cause of deaths worldwide. Another report from WHO from April 2020 states that approximately 1.9 billion adults are overweight across the globe, of which 650 million adults fall under the obese category. Chronic diseases have been rising significantly over the past decade. Growth in the number of patients has led to a major strain on the healthcare sector to use better biospecimen preserving techniques. This has led to major adoption and usage of biopreservation techniques and has facilitated market growth. Further, a major shortage of donors for the purpose of transplantation has increased the global demand for regenerative medicines. Regenerative medicines are used for controlling and treating multiple chronic diseases and degenerative conditions. Regenerative medicines extensively require biopreservation technique to keep the integrity and functionality intact. Growing usage of regenerative medicines has directly helped the demand for biopreservation to grow exponentially. Also, growing testing by the general population owing to multiple health conditions has increased the strain on the healthcare sector to preserve biospecimens. The growing load of preservation has directly increased the demand for biopreservation techniques.
High costs involved in biopreservation, stability issues, and development of cheaper techniques are restraining the market growth
Biopreservation is an advanced preservation technique and usually requires high costs owing to costly processes and equipment used during the preservation process. Biopreservation further has major stability issues with occurrences of tissue injuries during thawing and freezing. Also, with the development of cheap and cost-effective preservation techniques such as room temperature preservation processes will hamper the market growth.
Increasing investments in R&D of new drugs, growing bio-banks, and government initiatives to create lucrative market opportunities
There have been major investments by public and private organizations towards research and development activities related to the development of new drugs, which could potentially help fight the growing cases of chronic diseases. The major surge in investments is aimed at providing access to advanced products and quality healthcare that includes biopreservation facilities. The rising number of biobanks, which preserve biospecimens specifically has created massive growth opportunities for the biopreservation market. Governments across the globe are taking multiple initiatives to support cell therapies in the treatment of various diseases. Government healthcare initiatives are providing grants, contracts, and funds for research work, which has led to increased expenditure in R&D activities by organizations. This has facilitated significant growth in the biopreservation technology and also has led to wider adoption of advanced bio-preservation techniques. These advancements include the formulation of next-generation cryopreservation techniques, hypothermic storage processes, and integrate and design nanoscale technologies. All these factors are majorly increasing the demand for biopreservation techniques and creating lucrative market opportunities.
Biopreservation Market, by Type:
Equipment segment to be most lucrative till 2027
The equipment segment will have a dominating share in the global market and is expected to register a significant revenue during the forecast timeframe. Growing government initiatives coupled with rising investments in research and development to support cell and gene therapies for the treatment of multiple chronic diseases and degenerative conditions is facilitating the growth of the segments. Further, increased demand for biopreservation equipment by growing bio-banks across the globe for the preservation of plasma, cell, tissue, and DNA is helping the market to grow. Also, biopreservation equipment are being majorly adopted owing to the benefits such as low maintenance, high cost-efficiency, and adequate storage space.
Biopreservation Market, by Biospecimen:
Human tissue segment to register maximum growth
The human tissue segment is anticipated to register maximum growth in the biopreservation market during the forecast period. Growing cases of chronic diseases, degenerative conditions, and obesity have led to the rise in the human tissue segment. Further, an increasing number of openings of new biobanks and growing spending on R&D has led to the increased research work on human tissues to develop regenerative medicines.
Biopreservation Market, by Application:
A Therapeutic segment to grow significantly
The therapeutic segment is expected to grow significantly in the biopreservation market during the forecast timeframe. The segment’s growth is majorly due to the advancements in personalized medicines, treatment techniques, regenerative medicines, rising trend of cord blood banking, and growing cases of chronic diseases across the globe. All these factors are causing a rise in the demand for therapeutic applications and are facilitating the growth of the biopreservation market.
Biopreservation Market, by End User:
Biobank segment to grow at a fast pace
Biobank segment is anticipated to grow at a fast pace in the biopreservation market during the forecast period. Growing numbers of biobanks across the globe have attracted massive investments related to the research and development activities. They are extensively using biopreservation techniques to develop regenerative medicines. Also, technological advancements and government initiatives have motivated biobanks to opt for biopreservation techniques and equipment.
Biopreservation Market, by Region:
North America to hold the largest market share in the forecast period
The North America region is expected to hold the largest market share in the biopreservation market during the forecast timeframe. Rising awareness of personalized medicines, growing research activities related to regenerative medicines, growing cases of obesity, and chronic diseases are the major factors driving the regional market growth. Moreover, increasing investments in research and development in the life sciences mainly in the U.s and Canada further propelling the market growth.
Asia-Pacific region to grow exponentially by 2027
The Asia-Pacific region is anticipated to grow exponentially in the biopreservation market in the projected timeframe. Growing government initiatives, massively rising cases of chronic diseases and degenerative conditions, and increased investments in research development are the major factors facilitating the regional market growth. Furthermore, growing adoption by hospitals and the massive opening of new biobanks are further boosting the market growth.
Key Participants in the Global Biopreservation Market:
Merger & acquisition and advanced product development are the frequent strategies followed by the market players
Source: Research Dive Analysis
Some of the significant biopreservation market players include ThermoGenesis Corp., Thermo Fisher Scientific Inc., Exact Sciences Corporation, Merck KGaA, BioLifeSolutions Inc., Worthington Industries, Inc., Avantor, Inc., Bio-Techne., Chart Industries and BioCision.
Biopreservation market players are emphasizing more on merger & acquisition and advanced product development. These strategies implemented by established organizations. To emphasize more on the competitor analysis of market players, Porter’s five forces model is explained in the report.
|
Aspect |
Particulars |
|
Historical Market Estimations |
2018-2019 |
|
Base Year for Market Estimation |
2019 |
|
Forecast timeline for Market Projection |
2020-2027 |
|
Geographical Scope |
North America, Europe, Asia-Pacific, LAMEA |
|
Segmentation by Type |
|
|
Segmentation by Biospecimen |
|
|
Segmentation by Application |
|
|
Segmentation by End User |
|
|
Key Countries Covered |
U.S., Canada, Germany, France, Spain, Russia, Japan, China, India, South Korea, Australia, Brazil, and Saudi Arabia |
|
Key Companies Profiled |
|
Q1. Which are the leading companies in the biopreservation market?
A. Thermo Fisher Scientific Inc., Merck KGaA, and BioLifeSolutions Inc. are the leading companies in the biopreservation market.
Q2. Which region possesses greater investment opportunities in the coming future?
A. The Asia-Pacific region possesses great investment opportunities for investors to witness the most promising growth in the future.
Q3. What are the strategies opted by the leading players in this market?
A. Technological advancements, product development, along with joint ventures are the key strategies opted by the operating companies in this market.
Q4. Which companies are investing more in R&D practices?
A. BioLifeSolutions Inc. and Merck KGaA are investing more in R&D practices.
-
1. RESEARCH METHODOLOGY
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
-
2. REPORT SCOPE
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on Global Biopreservation Market
-
3. EXECUTIVE SUMMARY
-
4. MARKET OVERVIEW
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on Biopreservation Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
-
5. Biopreservation Market, By End Use
5.1. Overview
5.2 Equipment
5.2.1 Definition, key trends, growth factors, and opportunities
5.2.2 Market size analysis, by region, 2020-2027
5.2.3 Market share analysis, by country, 2020-2027
5.3 Media
5.3.1 Definition, key trends, growth factors, and opportunities
5.3.2 Market size analysis, by region, 2020-2027
5.3.3 Market share analysis, by country, 2020-2027
5.4 Laboratory information management system (LIMS)
5.4.1 Definition, key trends, growth factors, and opportunities
5.4.2 Market size analysis, by region, 2020-2027
5.4.3 Market share analysis, by country, 2020-2027
5.5 Research Dive Exclusive Insights
5.5.1 Market attractiveness
5.5.2 Competition heatmap
-
6. Biopreservation Market, By Technology
6.1. Overview
6.2 Regenerative Medicine
6.2.1 Definition, key trends, growth factors, and opportunities
6.2.2 Market size analysis, by region, 2020-2027
6.2.3 Market share analysis, by country, 2020-2027
6.3 Biobanking
6.3.1 Definition, key trends, growth factors, and opportunities
6.3.2 Market size analysis, by region, 2020-2027
6.3.3 Market share analysis, by country, 2020-2027
6.4 Drug Discovery
6.4.1 Definition, key trends, growth factors, and opportunities
6.4.2 Market size analysis, by region, 2020-2027
6.4.3 Market share analysis, by country, 2020-2027
6.5 Research Dive Exclusive Insights
6.5.1 Market attractiveness
6.5.2 Competition heatmap
-
7. Biopreservation Market, By Deployment Mode
7.1. Overview
7.2 CD34+
7.2.1 Definition, key trends, growth factors, and opportunities
7.2.2 Market size analysis, by region, 2020-2027
7.2.3 Market share analysis, by country, 2020-2027
7.3 CD19+
7.3.1 Definition, key trends, growth factors, and opportunities
7.3.2 Market size analysis, by region, 2020-2027
7.3.3 Market share analysis, by country, 2020-2027
7.4 MSC
7.4.1 Definition, key trends, growth factors, and opportunities
7.4.2 Market size analysis, by region, 2020-2027
7.4.3 Market share analysis, by country, 2020-2027
7.5 iPSC
7.5.1 Definition, key trends, growth factors, and opportunities
7.5.2 Market size analysis, by region, 2020-2027
7.5.3 Market share analysis, by country, 2020-2027
7.6 hESC
7.6.1 Definition, key trends, growth factors, and opportunities
7.6.2 Market size analysis, by region, 2020-2027
7.6.3 Market share analysis, by country, 2020-2027
7.7 Tumor Cells
7.7.1 Definition, key trends, growth factors, and opportunities
7.7.2 Market size analysis, by region, 2020-2027
7.7.3 Market share analysis, by country, 2020-2027
7.8 Research Dive Exclusive Insights
7.8.1 Market attractiveness
7.8.2 Competition heatmap
8. Biopreservation Market, By Region
8.1 North America
8.1.1 U.S
8.1.1.1 Market size analysis, By End Use, 2020-2027
8.1.1.2 Market size analysis, By Technology, 2020-2027
8.1.1.3 Market size analysis, By Deployment Mode, 2020-2027
8.1.2 Canada
8.1.2.1 Market size analysis, By End Use, 2020-2027
8.1.2.2 Market size analysis, By Technology, 2020-2027
8.1.2.3 Market size analysis, By Deployment Mode, 2020-2027
8.1.3 Mexico
8.1.3.1 Market size analysis, By End Use, 2020-2027
8.1.3.2 Market size analysis, By Technology, 2020-2027
8.1.3.3 Market size analysis, By Deployment Mode, 2020-2027
8.1.4 Research Dive Exclusive Insights
8.1.4.1 Market attractiveness
8.1.4.2 Competition heatmap
8.2 Europe
8.2.1 Germany
8.2.1.1 Market size analysis, By End Use, 2020-2027
8.2.1.2 Market size analysis, By Technology, 2020-2027
8.2.1.3 Market size analysis, By Deployment Mode, 2020-2027
8.2.2 UK
8.2.2.1 Market size analysis, By End Use, 2020-2027
8.2.2.2 Market size analysis, By Technology, 2020-2027
8.2.2.3 Market size analysis, By Deployment Mode, 2020-2027
8.2.3 France
8.2.3.1 Market size analysis, By End Use, 2020-2027
8.2.3.2 Market size analysis, By Technology, 2020-2027
8.2.3.3 Market size analysis, By Deployment Mode, 2020-2027
8.2.4 Spain
8.2.4.1 Market size analysis, By End Use, 2020-2027
8.2.4.2 Market size analysis, By Technology, 2020-2027
8.2.4.3 Market size analysis, By Deployment Mode, 2020-2027
8.2.5 Italy
8.2.5.1 Market size analysis, By End Use, 2020-2027
8.2.5.2 Market size analysis, By Technology, 2020-2027
8.2.5.3 Market size analysis, By Deployment Mode, 2020-2027
8.2.6 Rest of Europe
8.2.6.1 Market size analysis, By End Use, 2020-2027
8.2.6.2 Market size analysis, By Technology, 2020-2027
8.2.6.3 Market size analysis, By Deployment Mode, 2020-2027
8.2.7 Research Dive Exclusive Insights
8.2.7.1 Market attractiveness
8.2.7.2 Competition heatmap
8.3 Asia-Pacific
8.3.1 China
8.3.1.1 Market size analysis, By End Use, 2020-2027
8.3.1.2 Market size analysis, By Technology, 2020-2027
8.3.1.3 Market size analysis, By Deployment Mode, 2020-2027
8.3.2 Japan
8.3.2.1 Market size analysis, By End Use, 2020-2027
8.3.2.2 Market size analysis, By Technology, 2020-2027
8.3.2.3 Market size analysis, By Deployment Mode, 2020-2027
8.3.3 India
8.3.3.1 Market size analysis, By End Use, 2020-2027
8.3.3.2 Market size analysis, By Technology, 2020-2027
8.3.3.3 Market size analysis, By Deployment Mode, 2020-2027
8.3.4 Australia
8.3.4.1 Market size analysis, By End Use, 2020-2027
8.3.4.2 Market size analysis, By Technology, 2020-2027
8.3.4.3 Market size analysis, By Deployment Mode, 2020-2027
8.3.5 South Korea
8.3.5.1 Market size analysis, By End Use, 2020-2027
8.3.5.2 Market size analysis, By Technology, 2020-2027
8.3.5.3 Market size analysis, By Deployment Mode, 2020-2027
8.3.6 Rest of Asia-Pacific
8.3.6.1 Market size analysis, By End Use, 2020-2027
8.3.6.2 Market size analysis, By Technology, 2020-2027
8.3.6.3 Market size analysis, By Deployment Mode, 2020-2027
8.3.7 Research Dive Exclusive Insights
8.3.7.1 Market attractiveness
8.3.7.2 Competition heatmap
8.4 LAMEA
8.4.1 Brazil
8.4.1.1 Market size analysis, By End Use, 2020-2027
8.4.1.2 Market size analysis, By Technology, 2020-2027
8.4.1.3 Market size analysis, By Deployment Mode, 2020-2027
8.4.2 Saudi Arabia
8.4.2.1 Market size analysis, By End Use, 2020-2027
8.4.2.2 Market size analysis, By Technology, 2020-2027
8.4.2.3 Market size analysis, By Deployment Mode, 2020-2027
8.4.3 UAE
8.4.3.1 Market size analysis, By End Use, 2020-2027
8.4.3.2 Market size analysis, By Technology, 2020-2027
8.4.3.3 Market size analysis, By Deployment Mode, 2020-2027
8.4.4 South Africa
8.4.4.1 Market size analysis, By End Use, 2020-2027
8.4.4.2 Market size analysis, By Technology, 2020-2027
8.4.4.3 Market size analysis, By Deployment Mode, 2020-2027
8.4.5 Rest of LAMEA
8.4.5.1 Market size analysis, By End Use, 2020-2027
8.4.5.2 Market size analysis, By Technology, 2020-2027
8.4.5.3 Market size analysis, By Deployment Mode, 2020-2027
8.4.6 Research Dive Exclusive Insights
8.4.6.1 Market attractiveness
8.4.6.2 Competition heatmap
9. Competitive Landscape
9.1 Top winning strategies, 2020-2027
9.1.1 By strategy
9.1.2 By year
9.2 Strategic overview
9.3 Market share analysis, 2020-2027
10. Company Profiles
10.1 Atlanta Biologics
10.1.1 Overview
10.1.2 Business segments
10.1.3 Product portfolio
10.1.4 Financial performance
10.1.5 Recent developments
10.1.6 SWOT analysis
10.2 BioCision
10.2.1 Overview
10.2.2 Business segments
10.2.3 Product portfolio
10.2.4 Financial performance
10.2.5 Recent developments
10.2.6 SWOT analysis
10.3 BioLife Solutions
10.3.1 Overview
10.3.2 Business segments
10.3.3 Product portfolio
10.3.4 Financial performance
10.3.5 Recent developments
10.3.6 SWOT analysis
10.4 Biomatrica
10.4.1 Overview
10.4.2 Business segments
10.4.3 Product portfolio
10.4.4 Financial performance
10.4.5 Recent developments
10.4.6 SWOT analysis
10.5 Chart MVE Biomedical
10.5.1 Overview
10.5.2 Business segments
10.5.3 Product portfolio
10.5.4 Financial performance
10.5.5 Recent developments
10.5.6 SWOT analysis
10.6 Custom Biogenic Systems
10.6.1 Overview
10.6.2 Business segments
10.6.3 Product portfolio
10.6.4 Financial performance
10.6.5 Recent developments
10.6.6 SWOT analysis
10.7 LabVantage Solutions
10.7.1 Overview
10.7.2 Business segments
10.7.3 Product portfolio
10.7.4 Financial performance
10.7.5 Recent developments
10.7.6 SWOT analysis
10.8 Panasonic Biomedical
10.8.1 Overview
10.8.2 Business segments
10.8.3 Product portfolio
10.8.4 Financial performance
10.8.5 Recent developments
10.8.6 SWOT analysis
10.9 Qiagen
10.9.1 Overview
10.9.2 Business segments
10.9.3 Product portfolio
10.9.4 Financial performance
10.9.5 Recent developments
10.9.6 SWOT analysis
10.10 Taylor-Wharton Cryogenics
10.10.1 Overview
10.10.2 Business segments
10.10.3 Product portfolio
10.10.4 Financial performance
10.10.5 Recent developments
10.10.6 SWOT analysis
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com
